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Background: Hybrid coronary revascularization (HCR) is increasingly used to treat multi-vessel coronary artery disease (CAD) that includes 
stenoses in the proximal left anterior descending artery (LAD) and at least one other coronary artery, but its effectiveness has not been rigorously 
evaluated. This NIH-funded, multi-center, prospective, observational study, conducted to inform the design of a pivotal trial, explored the 
characteristics and outcomes of patients undergoing clinically indicated HCR and percutaneous coronary intervention (PCI) for hybrid-eligible CAD.
methods: Over 18 months, 200 HCR and 98 multi-vessel PCI patients were enrolled at 11 sites. The primary outcome was MACCE (death, stroke, 
myocardial infarction [MI], repeat revascularization) ≤ 12 months post-intervention. Cox proportional hazards models were used to model time to 
first MACCE event. Propensity scores were used to balance for baseline characteristics of groups.
results: Patients’ mean age was 64.2 ± 11.5 years, 25.5% were female, 38.6% diabetic, and 4.7% had prior stroke. Thirty percent had 3-vessel 
CAD, and the mean SYNTAX score was 19.7. The crude MACCE rate was 0.143 events/patient-year (11%) in the HCR group and 0.119 events/
patient-year (10%) in the PCI group. Adjusted for baseline risk, MACCE rates were similar between groups within 12 months post-intervention 
(HR=1.063, p=0.80), and during median 17.5 months follow-up (HR=0.868, p=0.53).
conclusions: These observational data, from this first multi-center study of HCR, suggest that there is no difference in MACCE rates over 12 
months between multi-vessel PCI and HCR, an emerging treatment paradigm. Thus equipoise exists to conduct a much needed comparative 
effectiveness trial of these two revascularization strategies.
